{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-042663","form_type":"8-K","ticker":"TERN","cik":"0001831363","company_name":"Terns Pharmaceuticals, Inc.","filed_at":"2025-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.146506+00:00","generated_at":"2026-05-24T10:44:22.964349+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Terns Pharma reports FY2024 net loss of $88.9M; cash runway into 2028; clinical milestones for CML and obesity","bullets":["FY2024 net loss $88.9M ($1.12/share), vs $90.2M in FY2023; R&D expenses $70.1M, G&A $31.8M.","Cash, cash equivalents and marketable securities $358.2M as of Dec 31, 2024, up from $263.4M; expected runway into 2028.","TERN-701 Phase 1 CARDINAL dose expansion to start 2Q25, with additional safety/efficacy data in 4Q25.","TERN-601 Phase 2 FALCON enrolled first patient in March 2025; 12-week top-line data expected 4Q25.","Appointed Andrew Gengos as CFO and Robert Azelby to board in February 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-042663","json":"https://secwatch.observer/filing/0000950170-25-042663.json","markdown":"https://secwatch.observer/filing/0000950170-25-042663.md","text":"https://secwatch.observer/filing/0000950170-25-042663.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831363/000095017025042663/0000950170-25-042663-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831363/000095017025042663/tern-20250320.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T10:44:22.964349+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001104659-26-068983","ticker":"GMRS","company_name":"GMR Solutions Inc.","filed_at":"2026-06-01T20:45:55+00:00","headline":"GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068983","json":"https://secwatch.observer/filing/0001104659-26-068983.json","markdown":"https://secwatch.observer/filing/0001104659-26-068983.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1898718/000110465926068983/0001104659-26-068983-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1898718/000110465926068983/gmrs-20260601x8k.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-039379","ticker":null,"company_name":"DAVEY TREE EXPERT CO","filed_at":"2026-06-01T17:50:11+00:00","headline":"Davey Tree Q1 net loss widens to $10.7M; revenue flat at $435.8M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039379","json":"https://secwatch.observer/filing/0001628280-26-039379.json","markdown":"https://secwatch.observer/filing/0001628280-26-039379.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/277638/000162828026039379/0001628280-26-039379-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/277638/000162828026039379/davey-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001437749-26-018927","ticker":"RMCF","company_name":"Rocky Mountain Chocolate Factory, Inc.","filed_at":"2026-06-01T13:15:11+00:00","headline":"Rocky Mountain Chocolate Factory Q4 revenue down 24% to $6.8M; net loss per share widens to $0.38","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018927","json":"https://secwatch.observer/filing/0001437749-26-018927.json","markdown":"https://secwatch.observer/filing/0001437749-26-018927.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1616262/000143774926018927/0001437749-26-018927-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1616262/000143774926018927/rmcfd20260531_8k.htm"},"side_by_side_evidence":null},{"accession":"0001520138-26-000196","ticker":"FNGR","company_name":"FingerMotion, Inc.","filed_at":"2026-05-29T21:12:33+00:00","headline":"FingerMotion FY2026 revenue down 32% to $24.1M; net loss widens to $7.0M","event_type":"earnings","sec_items":["2.02","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001520138-26-000196","json":"https://secwatch.observer/filing/0001520138-26-000196.json","markdown":"https://secwatch.observer/filing/0001520138-26-000196.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1602409/000152013826000196/0001520138-26-000196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1602409/000152013826000196/fngr-05292026_8k.htm"},"side_by_side_evidence":null},{"accession":"0000885245-26-000025","ticker":"BKE","company_name":"BUCKLE INC","filed_at":"2026-05-29T19:38:39+00:00","headline":"Buckle Q1 net income $46.9M ($0.93/share), sales up 6.1% to $288.7M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000885245-26-000025","json":"https://secwatch.observer/filing/0000885245-26-000025.json","markdown":"https://secwatch.observer/filing/0000885245-26-000025.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/885245/000088524526000025/0000885245-26-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885245/000088524526000025/bke-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-062458","ticker":"HIND","company_name":"Vyome Holdings, Inc","filed_at":"2026-05-29T12:42:42+00:00","headline":"Vyome Q1 net loss $963K, cash $8.8M, inks JAK inhibitor licensing deal with Impetis","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062458","json":"https://secwatch.observer/filing/0001213900-26-062458.json","markdown":"https://secwatch.observer/filing/0001213900-26-062458.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000121390026062458/0001213900-26-062458-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000121390026062458/ea0292643-8k_vyome.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-062434","ticker":"ELMT","company_name":"Elmet Group Co.","filed_at":"2026-05-29T12:05:35+00:00","headline":"Elmet Group Q1 revenue up 21% to $56M; adjusted EBITDA +106% to $9.2M; record backlog $113M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062434","json":"https://secwatch.observer/filing/0001213900-26-062434.json","markdown":"https://secwatch.observer/filing/0001213900-26-062434.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2101698/000121390026062434/0001213900-26-062434-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2101698/000121390026062434/ea0292205-8k_elmet.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-246280","ticker":"GCO","company_name":"GENESCO INC","filed_at":"2026-05-29T11:07:04+00:00","headline":"Genesco reports Q1 sales beat, raises FY2027 EPS outlook; launches $40-50M cost program","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-246280","json":"https://secwatch.observer/filing/0001193125-26-246280.json","markdown":"https://secwatch.observer/filing/0001193125-26-246280.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/18498/000119312526246280/0001193125-26-246280-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/18498/000119312526246280/gco-20260529.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}